SCHEDULE APPOINTMENT: CALL 800.999.1249 OR SCHEDULE ONLINE
ASTRAZENECA (ANCHOR) ADULTS AGED 18 AND ABOVE ASTHMA STUDY
If you are interested in participating and believe you meet the requirements, please contact our research staff to learn more at 502.368.0732.
Explore More About These Research Trials
An easy way to track when your study milestones, treatments, or updates are expected.
ASTRAZENECA (ANCHOR) ADULTS AGED 18 AND ABOVE {ASTHMA STUDY}
- The product being studied, AIRSUPRA (albuterol and budesonide) inhalation aerosol for oral inhalation use.
- The purpose of the study: Assessment of Combination Short-Acting Bronchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care”
- Study duration: participants are expected to take part in this study for approximately twelve (12) months.
Key Inclusion
- At least 1 diagnosis of asthma prior to the enrollment date documented in patient record
- At least 1 severe asthma exacerbation within 12 months before enrollment date.
- At least 1 prescription filled for SABA-only inhaler (i.e., albuterol-only or levalbuterol-only inhalers) within 12 months before enrollment date.
Key Exclusion:
- Conditions with major respiratory diagnoses including COPD.
- Chronic use of oral corticosteroids (for any condition) within 3 months before enrollment date.
- History of AIRSUPRA use within 12 months before enrollment date.
Interested in hearing more about these Research Trials?
Please contact one of our staff at 502.368.0732 or fill out the form below: